Connection

Paul Nietert to Cost-Benefit Analysis

Back to Details
This is a "connection" page, showing publications Paul Nietert has written about Cost-Benefit Analysis.
Paul Nietert
Connection Strength
0.103
Cost-Benefit Analysis
  1. Cost-effectiveness of screening a population with chronic gastroesophageal reflux. Gastrointest Endosc. 2003 Mar; 57(3):311-8.
    View in: PubMed
    Score: 0.046
  2. Hospital admissions, length of stay, charges, and in-hospital death among patients with systemic sclerosis. J Rheumatol. 2001 Sep; 28(9):2031-7.
    View in: PubMed
    Score: 0.041
  3. A markov model of the cost effectiveness of olanzapine treatment for agitation and psychosis in Alzheimer's disease. Clin Drug Investig. 2008; 28(5):291-303.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.